Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clotting changes, including disseminated intravascular coagulation, during rapid renal-homograft rejection.

× No keyword cloud information.

34 in total

1. LEUKOCYTE GROUPING. A METHOD AND ITS APPLICATION.

Authors: J J VAN ROOD; A VAN LEEUWEN
Journal: J Clin Invest Date: 1963-09 Impact factor: 14.808

2. INDUCTION OF VISCOUS METAMORPHOSIS IN HUMAN BLOOD PLATELETS BY MEANS OTHER THAN BY THROMBIN.

Authors: M BETTEX-GALLAND; E F LUESCHER; G SIMON; P VASSALLI
Journal: Nature Date: 1963-12-14 Impact factor: 49.962

3. The thrombotic activity of activation product.

Authors: E S HENDERSON; S L RAPAPORT
Journal: J Clin Invest Date: 1962-02 Impact factor: 14.808

4. The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies.

Authors: R R PROCTOR; S I RAPAPORT
Journal: Am J Clin Pathol Date: 1961-09 Impact factor: 2.493

5. Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells.

Authors: F Kissmeyer-Nielsen; S Olsen; V P Petersen; O Fjeldborg
Journal: Lancet Date: 1966-09-24 Impact factor: 79.321

6. "Hyperacute" renal-homograft rejection in man.

Authors: G M Williams; D M Hume; R P Hudson; P J Morris; K Kano; F Milgrom
Journal: N Engl J Med Date: 1968-09-19 Impact factor: 91.245

7. Split products of fibrin in human renal disease.

Authors: E R Stiehm; C W Trygstad
Journal: Am J Med Date: 1969-05 Impact factor: 4.965

8. Shwartzman reaction after human renal homotransplantation.

Authors: T E Starzl; R A Lerner; F J Dixon; C G Groth; L Brettschneider; P I Terasaki
Journal: N Engl J Med Date: 1968-03-21 Impact factor: 91.245

Review 9. Human histocompatibility antigens of leukocytes.

Authors: P I Terasaki; D P Singal
Journal: Annu Rev Med Date: 1969 Impact factor: 13.739

10. Intravascular coagulation (IVC) in human renal allograft rejection.

Authors: G J Busch; W E Braun; C B Carpenter; J M Corson; E R Galvanek; E S Reynolds; J P Merrill; G J Dammin
Journal: Transplant Proc Date: 1969-03 Impact factor: 1.066

38 in total

1. Current policies in hepatic transplantation: candidacy of patients with alcoholic liver disease or preformed antidonor antibodies and a reappraisal of biliary duct reconstruction.

Authors: T E Starzl; C W Putnam; M Ishikawa; R Picache; B Husberg; C G Halgrimson; G Schroter; K A Porter
Journal: Ann N Y Acad Sci Date: 1975-04-25 Impact factor: 5.691

10. Modification of hyperacute canine renal homograft and pig-to-dog heterograft rejection by the intra-arterial infusion of citrate.

Authors: M Kux; H J Boehmig; H Amemiya; M Torisu; T Yokoyama; B Launois; M Popovtzer; C B Wilson; F J Dixon; T E Starzl
Journal: Surgery Date: 1971-07 Impact factor: 3.982

Clotting changes, including disseminated intravascular coagulation, during rapid renal-homograft rejection.

1. LEUKOCYTE GROUPING. A METHOD AND ITS APPLICATION.

2. INDUCTION OF VISCOUS METAMORPHOSIS IN HUMAN BLOOD PLATELETS BY MEANS OTHER THAN BY THROMBIN.

3. The thrombotic activity of activation product.

4. The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies.

5. Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells.

6. "Hyperacute" renal-homograft rejection in man.

7. Split products of fibrin in human renal disease.

8. Shwartzman reaction after human renal homotransplantation.

Review 9. Human histocompatibility antigens of leukocytes.

10. Intravascular coagulation (IVC) in human renal allograft rejection.

1. Current policies in hepatic transplantation: candidacy of patients with alcoholic liver disease or preformed antidonor antibodies and a reappraisal of biliary duct reconstruction.

2. History of clinical transplantation.

3. Clinical xenotransplantation.

Review 4. The pathology of renal homograft rejection. A review.

5. Human liver xenotransplantation.

6. The basis of allograft acceptance.

Review 7. The future of transplantation: with particular reference to chimerism and xenotransplantation.

Review 8. Early clinical xenotransplantation experiences-An interview with Thomas E. Starzl, MD, PhD.

9. Adult Living Donor Liver Transplantation with ABO-Incompatible Grafts: A German Single Center Experience.

10. Modification of hyperacute canine renal homograft and pig-to-dog heterograft rejection by the intra-arterial infusion of citrate.